Degnan Chris
Insider CIK 1741968 · GRTX Chief Financial Officer · VRCA Chief Financial Officer · URGN Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2026-10-08 | 2026-10-09 | 4,483 | — | $0 | 4,484 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2026-10-08 | 2026-10-09 | 2,202 | $36.69 | $80.8K | 4,561 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2026-10-08 | 2026-10-09 | 4,483 | — | — | 6,763 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2026-01-31 | 2026-02-03 | 32,609 | — | $0 | 32,609 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2025-10-08 | 2025-10-09 | 4,483 | — | $0 | 8,967 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2025-10-08 | 2025-10-09 | 2,203 | $16.85 | $37.1K | 2,280 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2025-10-08 | 2025-10-09 | 4,483 | — | $0 | 4,483 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2024-10-08 | 2024-10-09 | 74,142 | — | $0 | 74,142 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2024-10-08 | 2024-10-09 | 13,450 | — | $0 | 13,450 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2023-03-13 | 2023-03-14 | 10,000 | $1.96 | $19.6K | 10,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2023-02-25 | 2023-02-28 | 185,000 | — | $0 | 185,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2022-02-28 | 2022-03-02 | 135,000 | — | $0 | 135,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2021-01-26 | 2021-01-28 | 82,500 | — | $0 | 82,500 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2020-01-31 | 2020-02-04 | 74,435 | — | $0 | 74,435 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2019-11-06 | 2019-11-08 | 229,513 | — | $0 | 229,513 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2019-02-28 | 2019-03-04 | 44,000 | — | $0 | 44,000 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2018-06-19 | 2018-08-15 | 3,000 | $15.00 | $45.0K | 3,000 | SEC↗ |